Сравнительный анализ активности ретроэлементов в нормальных и опухолевых тканях человека

Список литературы

1. J. McPherson, et al., A physical map of the human genome. Nature, 2001.409(6822): p. 934−41.
2. E. Lander, et al., Initial sequencing and analysis of the human genome. Nature, 2001. 409(6822): p. 860−921.
3. J. Brosius, et al., RNAs from all categories generate retrosequences that may be exapted as novel genes or regulatory elements. Gene, 1999. 238(1): p. 115−34.
4. H. Kazazian, et al., LI retrotransposons shape the mammalian genome. Science, 2000. 289(5482): p. 1152−1153.
5. R. Lower, J. Lower, and R. Kurth, The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A, 1996. 93(11): p. 5177−5184.
6. I. Yulug, A. Yulug, and E. Fisher, The frequency and position of Alu repeats in cDNAs, as determined by database searching. Genomics, 1995.27(3): p. 544−548.
7. P. Medstrand, Retroelement distributions in the human genome: variations associated with age and proximity to genes. Genome Res, 2002. Oct- 12(10): p. 1483−95.
8. H. Kazazian, An estimated frequency of endogenous insertional mutations in humans. Nat Genet, 1999.22(2): p. 130.
9. P. Nouvel, The mammalian genome shaping activity of reverse transcriptase. Genetica, 1994. 93(1−3): p. 191−201.
10. C. Leib-Mosch and W. Seifarth, Evolution and biological significance of human retroelements. Virus Genes, 1995. 11(2−3): p. 133−45.
11. W. Chu, et al., Potential Alu function: regulation of the activity of double-stranded RNA-activated kinase PKR. Mol Cell Biol, 1998. 18(1): p. 58−68.
12. A. Florl, et al., DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer, 1999. 80(9): p. 13 121 321.
13. G. Alves, A. Tatro, and T. Fanning, Differential methylation of human LINE-1 retrotransposons in malignant cells. Gene, 1996. 176(1−2): p. 39−44.
14. M. Kidwell and D. Lisch, Transposable elements as sources of variation in animals and plants. Proc Natl Acad Sci USA, 1997. 94(15): p. 7704−7711.
15. P. Хесин, Непостоянство генома. 1984, Москва: Наука. 472−472.
16. J. Yoder, С. Walsh, and Т. Bestor, Cytosine methylation and the ecology of intragenomic parasites. Trends Genet, 1997. 13(8): p. 335−40.
17. A. Smit, The origin of interspersed repeats in the human genome. Curr Opin Genet Dev, 1996. 6(6): p. 743−8.
18. E. Whitelaw and D. Martin, Retrotransposons as epigenetic mediators of phenotypic variation in mammals. Nat Genet, 2001. 27(4): p. 361−5.
19. С. Esnault, J. Maestre, and T. Heidmann, Human LINE retrotransposons generate processed pseudogenes. Nat Genet, 2000. 24(4): p. 363−7.
20. R. DeBerardinis, et al., Rapid amplification of a retrotransposon subfamily is evolving the mouse genome. Nat Genet, 1998. 20(3): p. 288−90.
21. H. Kazazian, and J. Moran, The impact of LI retrotransposons on the human genome. Nat Genet, 1998.19(1): p. 19−24.
22. A. Scott, et al., Origin of the human LI elements: proposed progenitor genes deduced from a consensus DNA sequence. Genomics, 1987. 1(2): p. 113−25.
23. H. Hohjoh and M. Singer, Cytoplasmic ribonucleoprotein complexes containing human LINE-1 protein and RNA. Embo J, 1996.15(3): p. 630−9.
24. D. Leibold, et al., Translation of LINE-1 DNA elements in vitro and in human cells. Proc Natl Acad Sci USA, 1990. 87(18): p. 6990−4.
25. J. McMillan and M. Singer, Translation of the human LINE-1 element, LIHs. Proc Natl Acad Sci USA, 1993. 90(24): p. 11 533−7.
26. A. Smit, et al., Ancestral, mammalian-wide subfamilies of LINE-1 repetitive sequences. J Mol Biol, 1995. 246(3): p. 401−417.
27. M. Singer, et al., LINE-1: a human transposable element. Gene, 1993. 135(1−2): p. 183−8.
28. A. Clements and M. Singer, The human LINE-1 reverse transcriptase: effect of deletions outside the common reverse transcriptase domain. Nucleic Acids Res, 1998. 26(15): p. 3528−35.
29. S. Lee, J. Wong, and K. Collins, Human telomerase reverse transcriptase motifs required for elongation of a telomeric substrate. J Biol Chem, 2003.
30. Y. Miki, Retrotransposal integration of mobile genetic elements in human diseases. J Hum Genet., 1998. 43(2): p. 77−84.
31. J. Skowronski and M. Singer, Expression of a cytoplasmic LINE-1 transcript is regulated in a human teratocarcinoma cell line. Proc Natl Acad Sci USA, 1985. 82(18): p. 6050−4.
32. J. Goodier, E. Ostertag, and H. Kazazian, Transduction of З'-flanking sequences is common in LI retrotransposition. Hum Mol Genet, 2000. 9(4): p. 653−7.
33. V. Perepelitsa-Belancio and P. Deininger, RNA truncation by premature polyadenylation attenuates human mobile element activity. Nat Genet, 2003. 35(4): p. 363−6.
34. B. Brouha, et al., Hot Lis account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci USA, 2003. 100(9): p. 5280−5.
35. E. Ostertag and H. Kazazian, Biology of mammalian LI retrotransposons. Annu Rev Genet, 2001. 35: p. 501−38.
36. Y. Miki, etal., Disruption oftheAPC gene by a retrotransposal insertion of LI sequence in a colon cancer. Cancer Res, 1992. 52(3): p. 643−5.
37. Z. Yang, et al., Apolipoprotein (a) gene enhancer resides within a LINE element. J Biol Chem, 1998.273(2): p. 891−7.
38. S. Kurachi, et al., Genetic mechanisms of age regulation of human blood coagulation factor IX. Science, 1999. 285(5428): p. 739−43.
39. B. Shewchuk, N. Cooke, and S. Liebhaber, The human growth hormone locus control region mediates long-distance transcriptional activation independent of nuclear matrix attachment regions. Nucleic Acids Res, 2001. 29(16): p. 3356−61.
40. E.D. Sverdlov, Perpetually mobile footprints of ancient infections in human genome. FEBS Lett, 1998. 428(1−2): p. 1−6.
41. M. Haltmeier, et al., Identification of S71-related human endogenous retroviral sequences with full-length pol genes. Virology, 1995. 209(2): p. 550−560.
42. M. Cohen and E. Larsson, Human endogenous retroviruses. Bioessays, 1988. 9(6): p. 191−6.
43. M. Barbulescu, et al., Many human endogenous retrovirus К (HERV-K) proviruses are unique to humans. Curr Biol, 1999. 9: p. 861−868.
44. M. Knossl, R. Lower, and J. Lower, Expression of the human endogenous retrovirus HTDV/HERV-K is enhanced by cellular transcription factor YY1. J Virol, 1999. 73(2): p. 1254−1261.
45. H. Urnovitz and W. Murphy, Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin Microbiol Rev, 1996. 9(1): p. 72−99.
46. J. Martin, et al., Human endogenous retrovirus type I-related viruses have an apparently widespread distribution within vertebrates. J Virol, 1997. 71(1): p. 437−43.
47. M. Tristem, Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J Virol, 2000. 74(8): p. 3715−30.
48. E. Herniou, et al., Retroviral diversity and distribution in vertebrates. J Virol, 1998. 72(7): p. 5955−66.
49. A. Smit, Identification of a new, abundant superfamily of mammalian LTR-transposons. Nucleic Acids Res, 1993. 21(8): p. 1863−72.
50. M. Andersson, et al., Diversity of human endogenous retrovirus class II-like sequences. J Gen Virol, 1999. 80(Part 1): p. 255−260.
51. J. Hughes and J. Coffin, Human endogenous retrovirus К solo-LTR formation and insertional polymorphisms: implications for human and viral evolution. Proc Natl Acad Sci USA, 2004. 101(6): p. 1668−72.
52. S. Anderssen, et al., Comparative analyses of LTRs of the ERV-H family of primate-specific retrovirus-like elements isolated from marmoset, African green monkey, and man. Virology, 1997. 234(1): p. 14−30.
53. N. de Parseval, H. Alkabbani, and T. Heidmann, The long terminal repeats of the HERV-H human endogenous retrovirus contain binding sites for transcriptional regulation by the Myb protein. J Gen Virol, 1999. 80 (Pt 4): p. 841−5.
54. J. Mayer, E. Meese, and N. Mueller-Lantzsch, Human endogenous retrovirus К homologous sequences and their coding capacity in Old World primates. J Virol, 1998. 72(3): p. 1870−1875.
55. I. Lavrentieva, et al., Subfamilies and nearest-neighbour dendrogram for the LTRs of human endogenous retroviruses HERV-K mapped on human chromosome 19: physical neighbourhood does not correlate with identity level. Hum Genet, 1998. 102(1): p. 107−116.
56. Y. Lebedev, et al., Physical mapping of sequences homologous to an endogenous retrovirus LTR on human chromosome 19. Mol Gen Genet, 1995. 247(6): p. 742−748.
57. И. Артамонова, et al., Неслучайное распределение регуляторных элементов LTR эндогенных ретровирусов HERV-K на 22 хромосоме человека. Доклады академии наук, 2000. 372(1−6): р. 87−9.
58. S. Steinhuber, et al., Distribution of human endogenous retrovirus HERV-K genomes in humans and different primates. Hum Genet, 1995. 96(2): p. 188−192.
59. C. Leib-Mosch, et al., Genomic distribution and transcription of solitary HERV-K LTRs. Genomics, 1993. 18: p. 261−269.
60. V. Kapitonov and J. Jurka, The long terminal repeat of an endogenous retrovirus induces alternative splicing and encodes an additional carboxy-terminal sequence in the human leptin receptor. J Mol Evol, 1999. 48(2): p. 248−251.
61. P. Kowalski, et al., Genomic structure and evolution of a novel gene (PLA2L) with duplicated phospholipase A2-like domains. Genomics, 1997. 39(1): p. 38−46.
62. P. Kowalski and D. Mager, A human endogenous retrovirus suppresses translation of an associated fusion transcript, PLA2L. J Virol, 1998. 72(7): p. 6164−6168.
63. K. Kato, Description of the entire mRNA population by a 3' end cDNA fragment generated by class IIS restriction enzymes. Nucleic Acids Res, 1995. 23(18): p. 368 590.
64. T. Vinogradova, et al., Positioning of 72 potentially full size LTRs of human endogenous retroviruses HERV-K on the human chromosome 19 map. Occurrences of the LTRs in human gene sites. Gene, 1997. 199(1−2): p. 255−264.
65. S. Kurdyukov, et al., Full-sized HERV-K (HML-2) human endogenous retroviral LTR sequences on human chromosome 21: map locations and evolutionary history. Gene, 2001. 273(1): p. 51−61.
66. S. Baban, J. Freeman, and D. Mager, Transcripts from a novel human КЛАВ zinc finger gene contain spliced Alu and endogenous retroviral segments. Genomics, 1996. 33(3): p. 463−472.
67. A. Domansky, et al., Solitary HERV-K LTRs possess bi-directional promoter activity and contain a negative regulatory element in the U5 region. FEBS Lett, 2000. 472(2−3): p. 191−195.
68. M. Landry, Functional analysis of the endogenous retroviral promoter of the human endothelin В receptor gene. J Virol., 2003. Jul-77(13): p. 7459−66.
69. R. Waterston, et al., Initial sequencing and comparative analysis of the mouse genome. Nature, 2002. 420(6915): p. 520−62.
70. Б. Larsson and G. Andersson, Beneficial role of human endogenous retroviruses: Facts and hypotheses. Scand J Immunol, 1998. 48(4): p. 329−338.
71. C. Patience, D. Wilkinson, and R. Weiss, Our retroviral heritage. Trends Genet, 1997. 13(3): p. 116−120.
72. J. Harris, Placental endogenous retrovirus (ERV): structural, functional, and evolutionary significance. Bioessays, 1998. 20(4): p. 307−316.
73. J. Lyden, J.M.Mwenda, N. Rote, Ultrastructural characterization of endogenous retroviral particles isolated from normal human placentas. Biol Reprod., 1994. Jul-51(1): p. 152−7.
74. C. Leib-Mosch, et al., Expression and biological sugnificance of human endogenous retroviral sequences. Leukemia, 1992. 6 Suppl 3: p. 72S-75S.
75. W. Seifarth, et al., Retrovirus-like particles released from the human breast cancer cell line T47-D display type B- and C-related endogenous retroviral sequences. J Virol, 1995. 69(10): p. 6408−6416.
76. G. Simpson, et al., Endogenous D-type (HERV-K) related sequences are packaged into retroviral particles in the placenta and possess open reading frames for reverse transcriptase. Virology, 1996. 222(2): p. 451−456.
77. M. Lindeskog, et al., Coamplification and dispersion of adjacent human endogenous retroviral HERV-H and HERV-E elements- Presence of spliced hybrid transcripts in normal leukocytes. Virology, 1998. 244(1): p. 219−229.
78. M. Ono, M. Kawakami, and H. Ushikubo, Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J Virol, 1987. 61(6): p. 2059−2062.
79. A. Wilier, et al., Two groups of endogenous MMTV related retroviral env transcripts expressed in human tissues. Virus Genes, 1997. 15(2): p. 123−133.
80. N. Gotzinger, et al., Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours. J Gen Virol, 1996. 77(12): p. 29 832 990.
81. I. Brodsky, B. Foley, and D. Gillespie, Expression of human endogenous retrovirus (HERV-K) in chronic myeloid leukemia. Leuk Lymphoma, 1993. 11 (Suppl 1): p. 11 923.
82. K. Boiler, et al., Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology, 1993. 196(1): p. 349−353.
83. Q. Long, et al., A long terminal repeat of the human endogenous retrovirus ERV-9 is located in the 5' boundary area of the human beta- globin locus control region. Genomics, 1998. 54(3): p. 542−555.
84. W. Goodchild NL, Mager DL., A human endogenous long terminal repeat provides a polyadenylation signal to a novel, alternatively spliced transcript in normal placenta. Gene, 1992. 16(121(2)): p. 287−94.
85. E. Sverdlov, Retroviral regulators of gene expression in the human genome as possible factors for its evolution. Bioorg Khim, 1999.25(11): p. 821−827.
86. I. Afonina, et al., Efficient priming of PCR with short oligonucleotides conjugated to a minor groove binder. Nucleic Acids Res, 1997. 25(13): p. 2657−60.
87. П. Хиль, et al., Структурная характеристика четырех длинных концевых повторов (LTR) эндогенных ретровирусов человека и характеристикаих сайтов интеграции. Биоорганическая химия, 1997. 23(5): р. 434−440.
88. L. van de Lagemaat, et al., Transposable elements in mammals promote regulatory variation and diversification of genes with specialized functions. Trends Genet, 2003. 19(10): p. 530−6.
89. L. Chene, et al., High-level replication of human immunodeficiency virus in thymocytes requires NF-kappaB activation through interaction with thymic epithelial cells. J Virol, 1999. 73(3): p. 2064−73.
90. U. Schon, et al., Cell type-specific expression and promoter activity of human endogenous retroviral long terminal repeats. Virology, 2001.279(1): p. 280−291.
91. A. Caricasole, et al., Bone morphogenetic proteins and retinoic acid induce human endogenous retrovirus HERV-K expression inNT2Dl human embryonal carcinoma cells. Dev Growth Differ, 2000.42(4): p. 407−411.
92. L. Lania, et al., Structural and functional organization of the human endogenous retroviral ERV9 sequences. Virology, 1992. 191(1): p. 464−468.
93. S. Akopov, et al., Long terminal repeats of human endogenous retrovirus К family (HERV-K) specifically bind host cell nuclear proteins. FEBS Lett, 1998. 421(3): p. 229−233.
94. J. Liu, et al., The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression. Mol Cell Biol, 1997. 17(9): p. 5275−87.
95. P. Schneider, et al., The endogenous retroviral insertion in the human complement C4 gene modulates the expression of homologous genes by antisense inhibition. Immunogenetics, 2001. 53(1): p. 1−9.
96. C. Lin, D. Goldthwait, and D. Samols, Induction of transcription from the long terminal repeat of Moloney murine sarcoma provirus by UV-irradiation, x-irradiation, and phorbol ester. Proc Natl Acad Sci USA, 1990. 87(1): p. 36−40.
97. H. Herbst, M. Sauter, and N. Mueller-Lantzsch, Expression of human endogenous retrovirus К elements in germ cell and trophoblastic tumors. Am J Pathol, 1996. 149(5): p. 1727−1735.
98. R. Tonjes, et al., HERV-K: the biologically most active human endogenous retrovirus family. J Acquir Immune Defic Syndr Hum Retrovirol, 1996. 13: p. S261−267.
99. J. Blond, et al., Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol, 1999. 73(2): p. 1175−1185.
100. M. Boyd, et al., The human endogenous retrovirus ERV-3 is upregulated in differentiating placental trophoblast cells. Virology, 1993. 196: p. 905−909.
101. A. Cordonnier, J. Casella, and T. Heidmann, Isolation of novel human endogenous retrovirus-like elements with foamy virus-related pol sequence. J Virol, 1995. 69(9): p. 5890−5897.
102. N. Kato, et al., Tissue-specific expression of human provirus ERV3 mRNA in human placenta: two of the three ERV3 mRNAs contain human cellular sequences. J Virol, 1987. 61(7): p. 2182−21 891.
103. N. Kato, et al., Human proviral mRNAs down regulated in choriocarcinoma encode a zinc finger protein related to Kruppel. Mol Cell Biol, 1990. 10: p. 4401−4405.
104. K. Katsumata, et al., Tissue-specific high-level expression of human endogenous retrovirus-R in the human adrenal cortex. Pathobiology, 1998. 66(5): p. 209−215.
105. D. Langat, et al., Characterization of antigens expressed in normal baboon trophoblast and cross-reactive with HIV/SIV antibodies. J Reprod Immunol, 1999.42(1): p. 41−58.
106. E. Larsson, et al., Expression of the endogenous retrovirus ERV3 (HERV-R) during induced monocytic differentiation in the U-937 cell line. Int J Cancer, 1996. 67(3): p. 451−456.
107. E. Larsson, et al., Tissue and differentiation specific expression on the endogenous retrovirus ERV3 (HERV-R) in normal human tissues and during induced monocytic differentiation in the U-937 cell line. Leukemia, 1997. 3: p. 142−144.
108. G. Franklin, et al., Expression of human sequences related to those of mouse mammary tumor virus. J Virol, 1988. 62(4): p. 1203−10.
109. C. Kjellman, et al., HERV-F (XA34) is a full-length human endogenous retrovirus expressed in placental and fetal tissues. Gene, 1999. 239(1): p. 99−107.
110. T. Johansen, T. Holm, and E. Bjorklid, Members of the RTVL-H family of human endogenous retrovirus-like elements are expressed in placenta. Gene, 1989. 79(2): p. 259−67.
111. M. Sibata, et al., Human endogenous retroviruses: expression in various organs in vivo and its regulation in vitro. Leukemia, 1997. 3: p. 145−146.
112. G. Andersson, et al., Retroelements in the human MHC class II region. Trends Genet, 1998. 14(3): p. 109−114.
113. T. Bera, et al., Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma. Biochem Biophys Res Commun, 1998. 248(3): p. 835−40.
114. N. Amariglio and G. Rechavi, Insertional mutagenesis by transposable elements in the mammalian genome. Environ Mol Mutagen, 1993. 21(3): p. 212−8.
115. H. Herbst, et al., Gene products of human endogenous retrovirus (HERV)-K in germ cell and trophoblastic tumors. German. Verhandlungen der Deutschen Gesellschaft fur Pathologie, 1997. 81: p. 464−470.
116. K. Nakagawa and L. Harrison, The potential roles of endogenous retroviruses in autoimmunity. Immunol Rev, 1996. 152: p. 193−236.
117. S. Indraccolo, et al., Identification of three human sequences with viral superantigen-specific primers. Mamm Genome, 1995. 6(5): p. 339−344.
118. A. Bengtsson, et al., Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly (amino acids) in patients with systemic lupus erythematosus. Arthritis Rheum, 1996. 39(10): p. 1654−1663.
119. M. Turbeville, et al., Expression of a putative immunosuppressive protein in human tumors and tissues. Pathobiology, 1996. 64(5): p. 233−238.
120. M. Turbeville, et al., Characterization of a putative retroviral env-related human protein. Pathobiology, 1997. 65(3): p. 123−128.
121. G. Krieg, A. Perl, Endogenous retroviruses: potential etiologic agents in autoimmunity. FASEB J., 1992. 6((8)): p. 2537−44.
122. W. Vogetseder, et al., Detection of a 67-kD glycoprotein in human tumor cell lines by a monoclonal antibody established against a recombinant human endogenous retrovirus-K envelope-gene-encoded protein. Exp Clin Immunogenet, 1995. 12(2): p. 96−102.
123. H. Rasmussen, et al., Expression of endogenous retroviruses in blood mononuclear cells and brain tissue from multiple sclerosis patients. Mult Scler, 1995. 1(2): p. 82−87.
124. K. Badenhoop, et al., IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes, 1999.48(1): p. 215 218.
125. A. Muir, et al., The IDDMK (1,2)22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes. Diabetes, 1999.48(1): p. 219−222.
126. M. Pani, et al., Preliminary evidence that an endogenous retroviral long-terminal repeat (LTR13) at the HLA-DQB1 gene locus confers susceptibility to Addison’s disease. Clin Endocrinol (Oxf), 2002. 56(6): p. 773−7.
127. R. Landry, P. Medstrand, D. Mager, The opitz syndrome gene midl is transcribed from a human endogenous retroviral promoter. Mol Biol Evol., 2003. Nov-19(l 1): p. 193 442.132,133.134,135,136,137,138 139,140141,142 143,144145146147,
128. A. Schulte and A. Wellstein, Structure and phylogenetic analysis of an endogenous retrovirus inserted into the human growth factor gene pleiotrophin. J Virol, 1998. 72(7): p. 6065−6072.
129. F. Baribaud, et al., Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V (beta) domains. J Virol, 2001. 75(16): p. 7453−61.
130. A. Barnett, et al., Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss. J Virol, 1999. 73(8): p. 6634−45.
131. B. Morse, et al., Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature, 1988. 333(6168): p. 87−90.
132. E. Amariglio, et al., Identity of rearranged LINE/c-MYC junction sequences specific for the canine transmissible venereal tumor. Proc Natl Acad Sci USA, 1991. 88(18): p. 8136−9.
133. D. Givol, Activation of oncogenes by transposable elements. Biochem Soc Symp, 1986. 51: p. 183−96.
134. H. Kazazian, et al., Haemophilia A resulting from de novo insertion of LI sequences represents a novel mechanism for mutation in man. Nature, 1988. 332(6160): p. 164 166.
135. B. Moon and J. Friedman, The molecular basis of the obese mutation in ob2J mice. Genomics, 1997.42(1): p. 152−6.
136. A. Schulte, et al., Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. Proc Natl Acad Sci USA, 1996. 93(25): p. 14 759−14 764.
137. H. Roelofs, et al., Detection of human endogenous retrovirus type K-specific transcripts in testicular parenchyma and testicular germ cell tumors of adolescents and adults: clinical and biological implications. Am J Pathol, 1998. 153(4): p. 1277−1282.
138. Y. Lebedev, et al., Differences in HERV-K LTR insertions in orthologous loci of human and great apes. Gene, 2000. 247(1−2): p. 265−277.
139. A. Femino, et al., Visualization of single RNA transcripts in situ. Science, 1998. 280(5363): p. 585−90.
140. P. Nelson, et al., Negative selection: a method for obtaining low-abundance cDNAs using high-density cDNA clone arrays. Genet Anal, 1999. 15(6): p. 209−215.
141. A. Casau, et al., Germ cell expression of an isolated human endogenous retroviral long terminal repeat of the HERV-K/HTDV family in transgenic mice. J Virol, 1999. 73(12): p. 9976−9983.
142. C. Baust, et al., HERV-K-T47D-Related long terminal repeats mediate polyadenylation of cellular transcripts. Genomics, 2000. 66(1): p. 98−103.
143. D. Mager, et al., Endogenous retroviruses provide the primary polyadenylation signal for two new human genes. Genomics, 1999. 59(3): p. 255−263.
144. A. Feuchter and D. Mager, Functional heterogeneity of a large family of human LTR-like promoters and enhancers. Nucleic Acids Res, 1990. 18(5): p. 1261−1270.
145. H. Ashe, et al., Intergenic transcription and transinduction of the human beta-globin locus. Genes Dev, 1997. 11(19): p. 2494−2509.
146. J. Gribnau, et al., Intergenic transcription and developmental remodeling of chromatin subdomains in the human beta-globin locus. Mol Cell, 2000. 5(2): p. 377−386.
147. J. Pardinas, et al., Differential subtraction display: a unified approach for isolation of cDNAs from differentially expressed genes. Anal Biochem, 1998. 257(2): p. 161−8.
148. N. Ivanova and A. Belyavsky, Identification of differentially expressed genes by restriction endonuclease-based gene expression fingerprinting. Nucleic Acids Res, 1995. 23(15): p. 2954−8.
149. Y. Prashar and S. Weissman, Analysis of differential gene expression by display of 3' end restriction fragments of cDNAs. Proc Natl Acad Sci USA, 1996. 93(2): p. 65 963.
150. M. Matz, et al., Ordered differential display: a simple method for systematic comparison of gene expression profiles. Nucleic Acids Res, 1997. 25(12): p. 2541−2.
151. D. Rebrikov, et al., Complete genome sequence of a novel extrachromosomal viruslike element identified in planarian Girardia tigrina. BMC Genomics, 2002. 3(1): p. 15.
152. H. Herbst, et al., Human endogenous retrovirus (HERV)-K transcripts in germ cell and trophoblastic tumours. Apmis, 1998. 106(1): p. 216−20.
153. Grigor, A new classification of germ cell tumours of the testis. Eur Urol., 1993. 23(1): p. 93−100.
154. McGlynn, Trends in the incidence of testicular germ cell tumors in the United States. Cancer, 2003. Jan 1−97(1). p. 63−70.
155. J. Wan, et al., Cloning differentially expressed mRNAs. Nat Biotechnol, 1996. 14(13): p. 1685−91.
156. M. Schummer, et al., Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. Gene, 1999. 238(2): p. 375−85.
157. K. Eisfeld, et al., Binding of NF1 to the MMTV promoter in nucleosomes: influence of rotational phasing, translational positioning and histone HI. Nucleic Acids Res, 1997. 25(18): p. 3733−37 342.
158. U. Scherf, et al., A gene expression database for the molecular pharmacology of cancer. Nat Genet, 2000. 24(3): p. 236−244.
159. P. Medstrand and D. Mager, Human-specific integrations of the HERV-K endogenous retrovirus family. J Virol, 1998. 72(12): p. 9782−9787.
160. R. Tonjes, F. Czauderna, and R. Kurth, Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K. J Virol, 1999. 73(11): p. 9187−95.
161. G. Diculescu, The sources of variation in the human genome and genome instability in human cancers. Rom J Physiol, 1997. 34(1−4): p. 3−17.
162. R. Slebos, M. Resnick, and J. Taylor, Inactivation of the p53 tumor suppressor gene via a novel Alu rearrangement. Cancer Res, 1998. 58(23): p. 5333−5336.
163. K. Becker, et al., Binding of the ubiquitous nuclear transcription factor YY1 to a cis regulatory sequence in the human LINE-1 transposable element. Hum Mol Genet, 1993. 2(10): p. 1697−702.
164. K. Huebner, et al., The role of deletions at the FRA3B/FHIT locus in carcinogenesis. Recent Results Cancer Res, 1998. 154: p. 200−15.
165. K. Kuo, et al., Expression of transposon LINE-1 is relatively human-specific and function of the transcripts may be proliferation-essential. Biochem Biophys Res Commun, 1998. 253(3): p. 566−70.
166. H. Pomykala, et al., Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines. Mol Cell Biol, 1994. 14(11): p. 7604−10.
167. G. Swergold, Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol Cell Biol, 1990. 10(12): p. 6718−29.
168. Leuer, Somatic mosaicism in hemophilia A: a fairly common event. Am J Hum Genet, 2001. Jul-69(l): p. 75−87.
169. Moyhuddin, Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring. J Med Genet., 2003. Jun-40(6): p. 459−63.
170. Sippel, Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling. Am J Hum Genet, 1998. Mar-62(3): p. 610−9.
171. S. Boissinot, P. Chevret, and A. Furano, LI (LINE-1) retrotransposon evolution and amplification in recent human history. Mol Biol Evol, 2000. 17(6): p. 915−28.
172. E. Ostertag, et al., A mouse model of human LI retrotransposition. Nat Genet, 2002. 32(4): p. 655−60.
173. M. Matz, et al., Amplification of cDNA ends based on template-switching effect and step- out PCR. Nucleic Acids Res, 1999. 27(6): p. 1558−1560.
174. Автор выражает глубокую признательность и благодарность за создание творческой атмосферы, за помощь, поддержку и доброжелательное отношение всем сотрудникам и аспирантам Лаборатории Структуры и Функций Генов Человека ИБХ РАН.
175. Автор благодарен В. К. Потапову и Н. В. Скапцовой за сотрудничество и синтез олигонуклеотидных праймеров, без которых данная работа была бы невозможна.
176. Автор благодарен Сенюте Наталье Борисовне и Клейман Анне за сотрудничество и предоставленные для работы материалы.